MoneyWorks4Me

Shilpa Medicare informs about press release

11 Feb 2022 Evaluate
Shilpa Medicare has informed that Shilpa Medicare through its wholly owned subsidiary Shilpa Biologicals has entered in to a strategic tie-up for manufacturing arrangement with Mylab Discovery Solutions. In this regard, company enclosed the press release.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

806.00 -15.90 (-1.93%)
17-Aug-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.00
Dr. Reddys Labs. 1192.00
Cipla 1430.40
Lupin 2260.55
Zydus Lifesciences 1137.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: